Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis
Abstract
To discuss the scope and epidemiology of cancer therapy-induced mucositis.
Peer-reviewed articles and book chapters.
Mucositis is a frequent and costly complication of cancer treatment. The risk of cancer therapy-induced mucositis varies depending on a number of patient- and treatment-related factors.
An awareness of the risk factors associated with mucositis will allow nurses to identify cancer patients at greatest risk and incorporate supportive care measures into their management plans.
To access this article, please choose from the options below
PII: S0749-2081(03)00133-5
doi:10.1053/j.soncn.2003.10.002
© 2004 Elsevier Inc. All rights reserved.
